Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Liu, Nan ^a   Zhang, Yixian ^a   Fan, Lin ^a   Yuan, Mingzhou ^a   Du, Houwei ^a   Cheng, Ronghua ^a   Liu, Deshan ^a   Lin, Feifei ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; SURVIVIN; VASCULOTROPIN; BIRC5 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 2; INHIBITOR OF APOPTOSIS PROTEIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL HYPOXIA; CELL SURVIVAL; CONTROLLED STUDY; DNA MODIFICATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; TREATMENT RESPONSE; UPREGULATION; ANIMAL; BONE MARROW CELL; BRAIN; BRAIN INFARCTION; CELL DIFFERENTIATION; CYTOLOGY; GENETIC TRANSDUCTION; GENETICS; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SPRAGUE DAWLEY RAT; STROKE;

ANIMALS; BONE MARROW CELLS; BRAIN; BRAIN INFARCTION; CELL DIFFERENTIATION; CELL SURVIVAL; FIBROBLAST GROWTH FACTOR 2; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; STROKE; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959895117     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-105     Document Type: Article

References (23)

1. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370. 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C, 10931522.
2. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol 2002, 1:92-100. 10.1016/S1474-4422(02)00040-6, 12849513.
3. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011. 10.1161/01.STR.32.4.1005, 11283404.
4. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201. 10.1038/nm912, 12910262.
5. Chen J, Li Y, Wang L, Lu M, Chopp M. Caspase inhibition by Z-VAD increase the survival of grafted bone marrow cells and improves functional outcome after MCAO rats. J Neurol Sci 2002, 199:2417-2434.
6. Wei L, Cui L, Snider BJ, Rivkin M, Yu SS, Lee CS, Adams LD, Gottlieb DI, Johnson EM, Yu SP, Choi DW. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes function recovery after cerebral ischemia. Neurobiol Dis 2005, 19:183-193. 10.1016/j.nbd.2004.12.016, 15837573.
7. Hanabusa K, Nagaya N, Iwase T, Itoh T, Murakami S, Shimizu Y, Taki W, Miyatake K, Kangawa K. Adrenomedullin Enhances Therapeutic Potency of Mesenchymal Stem Cells After Experimental Stroke in Rats. Stroke 2005, 36:853-858. 10.1161/01.STR.0000157661.69482.76, 15746464.
8. Fan L, Lin C, Zhuo S, Chen L, Liu N, Luo Y, Fang J, Huang Z, Lin Y, Chen J. Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction. Eur J Heart Fail 2009, 11:1023-1030. 10.1093/eurjhf/hfp135, 19875403.
9. Friedenstein AJ, Petrakova KV, Kurolesova, Frolova GP. Heterotopic of bone marrow analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247. 10.1097/00007890-196803000-00009, 5654088.
10. Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004, 287:H2670-H2676. 10.1152/ajpheart.01071.2003, 15284059.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147. 10.1126/science.284.5411.143, 10102814.
12. Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G, Scarpa A, Dazzi F, Pizzolo G, Vinante F. HB-EGF/HER-1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multi-lineage differentiation. Blood 2005, 106:59-66. 10.1182/blood-2004-09-3645, 15755902.
13. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91. 10.1161/01.STR.20.1.84, 2643202.
14. Tohill M, Mantovani C, Wiberg M, Terenghi G. Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci Lett 2004, 362:200-203. 10.1016/j.neulet.2004.03.077, 15158014.
15. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. Intravenous Bone Marrow Stromal Cell Therapy Reduces Apoptosis and Promotes Endogenous Cell Proliferation After Stroke in Female Rat. J Neuro Res 2003, 73:778-786.
16. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH. An anti-apoptoric protein human surviving is a direct inhibitor of caspase-3 and 7. Biochemistry 2001, 40:1117-1123. 10.1021/bi001603q, 11170436.
17. Zhu W, Chen J, Cong X, Hu S, Chen X. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006, 24:416-425. 10.1634/stemcells.2005-0121, 16253984.
18. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003, 1843-1851.
19. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu Z, Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003, 92:692-699. 10.1161/01.RES.0000063425.51108.8D, 12609969.
20. Rüster B, Göttig S, Ludwig RJ, Bistrian R, Müller S, Seifried E, Gille J, Henschler R. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006, 108:3938-3944. 10.1182/blood-2006-05-025098, 16896152.
21. Segers VF, Van Riet I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJ, Kockx MM, De Keulenaer GW. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol 2006, 290:H1370-H1377. 10.1152/ajpheart.00523.2005, 16243916.
22. Leu S, Lin YC, Yuen CM, Yen CH, Kao YH, Sun CK, Yip HK. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 2010, 8:63. 10.1186/1479-5876-8-63, 2913939, 20584315.
23. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. stem cell 2009, 5:54-63.